PTC Therapeutics Inc. Stock
Price
Target price
€22.80
€22.80
-2.560%
-0.6
-2.560%
€41.81
18.04.24 / Stuttgart Stock Exchange
WKN: A1W0MW / Symbol: PTCT / Name: PTC Therapeutics / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
PTC Therapeutics Inc. Stock
We can see a decrease in the price for PTC Therapeutics Inc.. Compared to yesterday it has lost -€0.600 (-2.560%).
Currently there is a rather positive sentiment for PTC Therapeutics Inc. with 12 Buy predictions and 6 Sell predictions.
With a target price of 41 € there is a hugely positive potential of 79.82% for PTC Therapeutics Inc. compared to the current price of 22.8 €.
Our community identified positive and negative aspects for PTC Therapeutics Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the PTC Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of PTC Therapeutics Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of PTC Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc. | -2.560% | -9.524% | -13.636% | -50.649% | -9.524% | -43.564% | -28.189% |
| Ironwood Pharmaceuticals | -0.670% | -1.342% | -6.369% | -28.641% | -29.327% | -17.416% | -36.856% |
| Novocure Ltd | -1.720% | -14.085% | -11.150% | -80.505% | -20.736% | -92.957% | - |
| Iovance Biotherapeutics Inc. | -5.680% | -10.456% | -14.690% | 112.370% | 40.945% | -56.277% | - |
Comments
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Jefferies Financial Group Inc. from $33.00 to $35.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Show more
Ratings data for PTCT provided by MarketBeat